CBM-05 FUNCTIONAL DIFFERENCES BETWEEN PD-1(+) AND PD-1(–) CD4(+) T EFFECTOR CELLS IN HEALTHY DONORS AND PATIENTS WITH GLIOBLASTOMA

Documenti analoghi

• CBM-04 PD-1 EXPRESSION IDENTIFIES EXHAUSTED TUMOR INFILTRATING REGULATORY T CELLS IN GLIOBLASTOMA
  di: Lucca, Liliana, et al.
  Pubblicazione: (2015)
• Functional differences between PD-1(+) and PD-1(-) CD4(+) effector T cells in healthy donors and patients with glioblastoma multiforme
  di: Goods, Brittany A., et al.
  Pubblicazione: (2017)
• PD-1 marks dysfunctional regulatory T cells in malignant gliomas
  di: Lowther, Daniel E., et al.
  Pubblicazione: (2016)
• CBM-06 IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB ± IPILIMUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143
  di: Lowther, Daniel E., et al.
  Pubblicazione: (2015)
• Distinct Inflammatory Profiles of Myelin-Reactive T cells from Patients with Multiple Sclerosis
  di: Cao, Yonghao, et al.
  Pubblicazione: (2015)